SKYE Dana dhuwit perusahaan Skye Bioscience

Logo korporat perusahaan Skye Bioscience, Inc. (SKYE)

Skye Bioscience, Inc. (SKYE) is protected by patents for glaucoma treatment under strict FDA oversight, supported by a team of top-tier biologists. The change in cash balances on the GURU.Markets analytical chart contains up-to-date data, where the value of 0.01 corresponds to the current metric. The implementation of robotics in laboratories is currently accelerating the primary screening of new molecules for future drugs.

Aset likuid perusahaan: skyebioscience.com (SKYE) kanggo 12.04.2024 - 21.11.2026

Rincian analitis lan laporan data perusahaan Skye Bioscience (SKYE)

Analisis kabeh metrik perusahaan:SKYE Skye Bioscience, Inc.
Produk merek skyebioscience.com

This metric measures the current balance of liquid assets, determining the equilibrium between financial security and capital management efficiency. For Skye Bioscience, Inc. (SKYE), this reserve is critical when conducting costly trials for glaucoma and obesity drugs. By analyzing the company's cash position, an investor assesses the business's ability to withstand biopharmaceutical regulatory risks. The trend of this indicator objectively reflects the issuer's viability in the absence of stable profits.